References:
  1. Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM. Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms . 2019;8(1):55. Published 2019 Dec 28. doi:10.3390/microorganisms8010055
  2. Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood . 2009;113(23):5711-5719. doi:10.1182/blood-2008-10-143560
  3. Kim JY, Hong SY, Park WK, et al. Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation. PLoS One . 2020;15(9):e0238257. Published 2020 Sep 2. doi:10.1371/journal.pone.0238257
  4. Mori T, Kikuchi T, Koh M, et al. Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening. Bone Marrow Transplant . 2021;56(6):1266-1271. doi:10.1038/s41409-020-01176-8
  5. Larsson K, Lönnqvist B, Ringdén O, Hedquist B, Ljungman P. CMV retinitis after allogeneic bone marrow transplantation: a report of five cases. Transpl Infect Dis . 2002;4(2):75-79. doi:10.1034/j.1399-3062.2002.01018.x
  6. Crippa F, Corey L, Chuang EL, Sale G, Boeckh M. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation. Clin Infect Dis . 2001;32(2):214-219. doi:10.1086/318447
  7. Einsele H, Ljungman P, Boeckh M. How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation. Blood . 2020;135(19):1619-1629. doi:10.1182/blood.2019000956
  8. Vassallo F, Nuzzi R, Cattani I, et al. CMV retinitis in a stem cell transplant recipient treated with foscarnet intravitreal injection and CMV specific immunoglobulins. Ther Adv Hematol . 2020;11:2040620720975651. Published 2020 Dec 10. doi:10.1177/2040620720975651
  9. Marty FM, Ljungman P, Chemaly RF, et al. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med . 2017;377(25):2433-2444. doi:10.1056/NEJMoa1706640